Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7

Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172.dark field, aggregate formation produced by p72Q and inhibition of aggregation by Congo red (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Skogen, Michael, Roth, Jennifer, Yerkes, Sarah, Hetal Parekh-Olmedo, Kmiec, Eric
Format:	Bild
Sprache:	eng
Schlagworte:	Uncategorised
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Skogen, Michael Roth, Jennifer Yerkes, Sarah Hetal Parekh-Olmedo Kmiec, Eric
description	Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172.dark field, aggregate formation produced by p72Q and inhibition of aggregation by Congo red (0.2 μM or 1 μM) added concurrently with p72Q.
doi_str_mv	10.6084/m9.figshare.44129
format	Image
fullrecord	<record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_44129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_44129</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_441293</originalsourceid><addsrcrecordid>eNqdzr0KwjAUBeAsDqI-gFs2p9ZGi9rZv-51D5f0tr2QJiW5HXx7q-gLCAcOHDjwCbFWWXrITvm2L9KG2thBwDTP1a6Yi6rqfGB5TwKZTnpLrXejseiZaowSpsjBMzomsJI7DDDgyGRk44Msx2l3LXu3ifJCESFiclyKWQM24urbC6Fu18e5TGpgMMSoh0A9hKdWmX7DdF_oH0x_YPt_Pi9rsUu3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7</title><source>DataCite</source><creator>Skogen, Michael ; Roth, Jennifer ; Yerkes, Sarah ; Hetal Parekh-Olmedo ; Kmiec, Eric</creator><creatorcontrib>Skogen, Michael ; Roth, Jennifer ; Yerkes, Sarah ; Hetal Parekh-Olmedo ; Kmiec, Eric</creatorcontrib><description>Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172.dark field, aggregate formation produced by p72Q and inhibition of aggregation by Congo red (0.2 μM or 1 μM) added concurrently with p72Q.</description><identifier>DOI: 10.6084/m9.figshare.44129</identifier><language>eng</language><publisher>figshare</publisher><subject>Uncategorised</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>781,1895</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.44129$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Skogen, Michael</creatorcontrib><creatorcontrib>Roth, Jennifer</creatorcontrib><creatorcontrib>Yerkes, Sarah</creatorcontrib><creatorcontrib>Hetal Parekh-Olmedo</creatorcontrib><creatorcontrib>Kmiec, Eric</creatorcontrib><title>Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7</title><description>Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172.dark field, aggregate formation produced by p72Q and inhibition of aggregation by Congo red (0.2 μM or 1 μM) added concurrently with p72Q.</description><subject>Uncategorised</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2011</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqdzr0KwjAUBeAsDqI-gFs2p9ZGi9rZv-51D5f0tr2QJiW5HXx7q-gLCAcOHDjwCbFWWXrITvm2L9KG2thBwDTP1a6Yi6rqfGB5TwKZTnpLrXejseiZaowSpsjBMzomsJI7DDDgyGRk44Msx2l3LXu3ifJCESFiclyKWQM24urbC6Fu18e5TGpgMMSoh0A9hKdWmX7DdF_oH0x_YPt_Pi9rsUu3</recordid><startdate>20111231</startdate><enddate>20111231</enddate><creator>Skogen, Michael</creator><creator>Roth, Jennifer</creator><creator>Yerkes, Sarah</creator><creator>Hetal Parekh-Olmedo</creator><creator>Kmiec, Eric</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20111231</creationdate><title>Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7</title><author>Skogen, Michael ; Roth, Jennifer ; Yerkes, Sarah ; Hetal Parekh-Olmedo ; Kmiec, Eric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_441293</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Uncategorised</topic><toplevel>online_resources</toplevel><creatorcontrib>Skogen, Michael</creatorcontrib><creatorcontrib>Roth, Jennifer</creatorcontrib><creatorcontrib>Yerkes, Sarah</creatorcontrib><creatorcontrib>Hetal Parekh-Olmedo</creatorcontrib><creatorcontrib>Kmiec, Eric</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Skogen, Michael</au><au>Roth, Jennifer</au><au>Yerkes, Sarah</au><au>Hetal Parekh-Olmedo</au><au>Kmiec, Eric</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7</title><date>2011-12-31</date><risdate>2011</risdate><abstract>Copyright information:Taken from "Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease"BMC Neuroscience 2006;7():65-65.Published online 2 Oct 2006PMCID:PMC1609172.dark field, aggregate formation produced by p72Q and inhibition of aggregation by Congo red (0.2 μM or 1 μM) added concurrently with p72Q.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.44129</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	DOI: 10.6084/m9.figshare.44129
ispartof
issn
language	eng
recordid	cdi_datacite_primary_10_6084_m9_figshare_44129
source	DataCite
subjects	Uncategorised
title	Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease-7
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T20%3A47%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Skogen,%20Michael&rft.date=2011-12-31&rft_id=info:doi/10.6084/m9.figshare.44129&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_44129%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true